Literature DB >> 21769451

Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes.

Esther Landesman-Bollag1, Anna Belkina, Beth Hovey, Edward Connors, Charles Cox, David C Seldin.   

Abstract

The CK2 α and α' catalytic gene products have overlapping biochemical activity, but in vivo, their functions are very different. Deletion of both alleles of CK2α leads to mid-gestational embryonic lethality, while deletion of both alleles of CK2α' does not interfere with viability or development of embryos; however, adult CK2α'-/-males are infertile. To further elucidate developmental roles of CK2, and analyze functional overlap between the two catalytic genes, mice with combined knockouts were bred. Mice bearing any two CK2 catalytic alleles were phenotypically normal. However, inheritance of a single CK2α allele, without either CK2α' allele, resulted in partial embryonic lethality. Such mice that survived through embryogenesis were smaller at birth than littermate controls, and weighed less throughout life. However, their cardiac function and lifespan were normal. Fibroblasts derived from CK2α+/-CK2α'-/- embryos grew poorly in culture. These experiments demonstrate that combined loss of one CK2α allele and both CK2α' alleles leads to unique abnormalities of growth and development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769451      PMCID: PMC3397194          DOI: 10.1007/s11010-011-0967-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  18 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

Review 2.  Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

Authors:  James S Duncan; David W Litchfield
Journal:  Biochim Biophys Acta       Date:  2007-08-30

3.  Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.

Authors:  Mauro Salvi; Stefania Sarno; Luca Cesaro; Hideji Nakamura; Lorenzo A Pinna
Journal:  Biochim Biophys Acta       Date:  2009-01-31

4.  Protein kinase CK2 in mammary gland tumorigenesis.

Authors:  E Landesman-Bollag; R Romieu-Mourez; D H Song; G E Sonenshein; R D Cardiff; D C Seldin
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

5.  CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.

Authors:  Adam Siddiqui-Jain; Denis Drygin; Nicole Streiner; Peter Chua; Fabrice Pierre; Sean E O'Brien; Josh Bliesath; Mayuko Omori; Nanni Huser; Caroline Ho; Chris Proffitt; Michael K Schwaebe; David M Ryckman; William G Rice; Kenna Anderes
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 6.  Casein Kinase II: an attractive target for anti-cancer drug design.

Authors:  Ismail Muhamad Hanif; Ibrahim Muhammad Hanif; Muhammad Ali Shazib; Kashif Adil Ahmad; Shazib Pervaiz
Journal:  Int J Biochem Cell Biol       Date:  2010-06-15       Impact factor: 5.085

7.  The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development.

Authors:  David Y Lou; Isabel Dominguez; Paul Toselli; Esther Landesman-Bollag; Conor O'Brien; David C Seldin
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272

Review 8.  Protein kinase CK2 in human diseases.

Authors:  Barbara Guerra; Olaf-Georg Issinger
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 9.  Protein kinase CK2 as a druggable target.

Authors:  Stefania Sarno; Lorenzo A Pinna
Journal:  Mol Biosyst       Date:  2008-06-12

10.  Gene targeting of CK2 catalytic subunits.

Authors:  David C Seldin; David Y Lou; Paul Toselli; Esther Landesman-Bollag; Isabel Dominguez
Journal:  Mol Cell Biochem       Date:  2008-07-02       Impact factor: 3.396

View more
  9 in total

1.  CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.

Authors:  Sarah Lupp; Catalina Gumhold; Emmanuel Ampofo; Mathias Montenarh; Karen Rother
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

Review 2.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

3.  Protein kinase CK2 in development and differentiation.

Authors:  Claudia Götz; Mathias Montenarh
Journal:  Biomed Rep       Date:  2016-12-19

4.  De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.

Authors:  Volkan Okur; Megan T Cho; Lindsay Henderson; Kyle Retterer; Michael Schneider; Shannon Sattler; Dmitriy Niyazov; Meron Azage; Sharon Smith; Jonathan Picker; Sharyn Lincoln; Mark Tarnopolsky; Lauren Brady; Hans T Bjornsson; Carolyn Applegate; Amy Dameron; Rebecca Willaert; Berivan Baskin; Jane Juusola; Wendy K Chung
Journal:  Hum Genet       Date:  2016-04-05       Impact factor: 4.132

5.  Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.

Authors:  Andrea Baier; Jolanta Nazaruk; Anna Galicka; Ryszard Szyszka
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

6.  Down-regulation of CK2α correlates with decreased expression levels of DNA replication minichromosome maintenance protein complex (MCM) genes.

Authors:  Susanne Schaefer; Thomas K Doktor; Sabrina B Frederiksen; Kathleen Chea; Mirka Hlavacova; Gitte H Bruun; Maj Rabjerg; Brage S Andresen; Isabel Dominguez; Barbara Guerra
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.

Authors:  Estefania Alcaraz; Jordi Vilardell; Christian Borgo; Eduard Sarró; Maria Plana; Oriano Marin; Lorenzo A Pinna; José R Bayascas; Anna Meseguer; Mauro Salvi; Emilio Itarte; Maria Ruzzene
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

Review 8.  Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.

Authors:  Janeen H Trembley; Betsy T Kren; Muhammad Afzal; George A Scaria; Mark A Klein; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

9.  Casein kinase 2 attenuates brain injury induced by intracerebral hemorrhage via regulation of NR2B phosphorylation.

Authors:  Zhimin Sun; Qiyao Li; Xiaopeng Li; Yunpeng Shi; Chengrui Nan; Qianxu Jin; Xiaoyan Wang; Yayu Zhuo; Zongmao Zhao
Journal:  Front Cell Neurosci       Date:  2022-07-19       Impact factor: 6.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.